OPA1 and dementia: In this study, we assessed DNA amplification multiples of DRP1 and OPA1 in patients with normal cognitive function, mild cognitive impairment (MCI), and dementia;investigated their potential value as biomarkers for MCI and dementia; and explored the relationship between DNA amplification multiples of DRP1 and OPA1 and the risk of cognitive impairment.